Scalp Angiosarcoma Remission with Bevacizumab and Radiotherapy without Surgery: A Case Report and Review of the Literature.

Scalp Angiosarcoma Remission with Bevacizumab and Radiotherapy without Surgery: A Case Report and Review of the Literature.

De Yao Jocelyn T; Sun Danyu; Powell Angela T; Rehmus Esther H

Sarcoma

2011

2011-01

Angiosarcoma (AS) is a rare and aggressive vascular neoplasm with very poor prognosis. Patients with extensive cutaneous AS who are not surgical candidates have very limited options since there is no standard treatment. Treatment options include radiation, chemotherapy, and angiogenesis inhibitor with varying success rates. Here, we report a case an 88 year old patient with extensive scalp angiosarcoma having biopsy proven remission with bevacizumab and radiotherapy without undergoing surgery.

Male; Aged; Combined Modality Therapy; Antibodies; Radiotherapy; Disease Remission; 80 and Over; Sarcoma – Pathology; Monoclonal – Therapeutic Use; Monoclonal – Administration and Dosage; Sarcoma – Therapy; Scalp – Pathology; Vascular Neoplasms – Therapy

Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).

1–5